Nonalcoholic fatty liver disease (NAFLD): Pathogenesis and noninvasive diagnosis

32Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

Abstract

The global prevalence of nonalcoholic fatty liver disease (NAFLD) or metabolic associated fatty liver disease (MAFLD), as it is now known, has gradually increased. NAFLD is a disease with a spectrum of stages ranging from simple fatty liver (steatosis) to a severe form of steatosis, nonalcoholic steatohepatitis (NASH), which could progress to irreversible liver injury (fibrosis) and organ failure, and in some cases hepatocellular carcinoma (HCC). Although a liver biopsy remains the gold standard for accurate detection of this condition, it is unsuitable for clinical screening due to a higher risk of death. There is thus an increased need to find alternative techniques or tools for accurate diagnosis. Early detection for NASH matters for patients because NASH is the marker for severe disease progression. This review summarizes the current noninvasive tools for NAFLD diagnosis and their performance. We also discussed potential and newer alternative tools for diagnosing NAFLD.

Cite

CITATION STYLE

APA

Dorairaj, V., Sulaiman, S. A., Abu, N., & Murad, N. A. A. (2022, January 1). Nonalcoholic fatty liver disease (NAFLD): Pathogenesis and noninvasive diagnosis. Biomedicines. MDPI. https://doi.org/10.3390/biomedicines10010015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free